Healthcare provider profile · identity verified

Kenneth R Betts, MD

General Practice · EDGERTON, WI · NPI 1457435950

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	294	106
Rosuvastatin Calcium	Rosuvastatin Calcium	165	72
Levothyroxine Sodium	Levothyroxine Sodium	136	39
Omeprazole	Omeprazole	112	44
Amlodipine Besylate	Amlodipine Besylate	101	47
Lisinopril	Lisinopril	86	46
Losartan Potassium	Losartan Potassium	80	32
Metformin Hcl	Metformin Hcl	74	35
Metoprolol Tartrate	Metoprolol Tartrate	67	28
Furosemide	Furosemide	62	29
Tamsulosin Hcl	Tamsulosin Hcl	61	27
Myrbetriq	Mirabegron	60	suppressed
Eliquis	Apixaban	49	13
Carvedilol	Carvedilol	41	16
Fluticasone Propionate	Fluticasone Propionate	39	11
Gabapentin	Gabapentin	39	15
Metoprolol Succinate	Metoprolol Succinate	35	18
Atenolol	Atenolol	34	18
Warfarin Sodium	Warfarin Sodium	34	11
Montelukast Sodium	Montelukast Sodium	33	13
Albuterol Sulfate Hfa	Albuterol Sulfate	32	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	suppressed
Allopurinol	Allopurinol	31	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	12
Mirtazapine	Mirtazapine	30	15
Pantoprazole Sodium	Pantoprazole Sodium	30	13
Potassium Chloride	Potassium Chloride	30	11
Hydrochlorothiazide	Hydrochlorothiazide	28	12
Trazodone Hcl	Trazodone Hcl	28	13
Pioglitazone Hcl	Pioglitazone Hcl	26	12
Spironolactone	Spironolactone	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Famotidine	Famotidine	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Sertraline Hcl	Sertraline Hcl	24	11
Simvastatin	Simvastatin	24	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Clopidogrel	Clopidogrel Bisulfate	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Tramadol Hcl	Tramadol Hcl	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Ozempic	Semaglutide	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Topiramate	Topiramate	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Finasteride	Finasteride	13	suppressed
Imipramine Hcl	Imipramine Hcl	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Repaglinide	Repaglinide	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Pravastatin Sodium	Pravastatin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error